Aug 9 (Reuters) - Knight Therapeutics Inc GUD.TO :
* MEDISON BIOTECH LTD RAISES CONCERNS REGARDING KNIGHT THERAPEUTICS' Q2 FINANCIAL STATEMENTS AND GOVERNANCE RELATED ISSUES
* MEDISON BIOTECH LTD SAYS, TOGETHER WITH ITS AFFILIATES, OWNS MORE THAN 10.4 MILLION SHARES OR 7.5% OF KNIGHT THERAPEUTICS